- Home
- / Albert Labs
Albert Labs
Stock Price
€0
2024-10-29
Market Capitalization
€372.1 K
2024-10-29
Albert Labs Summary
Company Summary
- Overview
- Albert Labs is a clinical research and drug development company. It develops psilocybin therapeutics for cancer-related anxiety and depression and mental health indications.
- Type
- Public
- Status
- Active
- Founded
- 2009
- HQ
- Burnaby, CA | view all locations
- Website
- https://albertlabs.com/
- Cybersecurity rating
Table of Contents
LocationsView all
3 locations detected
Burnaby, BC HQ
Canada
6996 Merritt Ave
Porto, Porto
Portugal
R. Central da Gandra
Manchester, England
United Kingdom
61 Mosley St
Albert Labs Financials
Summary Financials
- Net income (Q3, 2023)
- ($C17.0K)
- EBIT (Q3, 2023)
- ($C11.0K)
- Enterprise value
- $382.1K
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026